IGC Pharma
25 hedge funds and large institutions have $692K invested in IGC Pharma in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
32% less capital invested
Capital invested by funds: $1.01M → $692K (-$322K)
Holders
25
Holding in Top 10
–
Calls
$37K
Puts
$6K
Top Buyers
| 1 | +$6.25K | |
| 2 | +$1.38K | |
| 3 | +$1.25K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$555 |
| 5 |
Morgan Stanley
New York
|
+$255 |
Top Sellers
| 1 | -$59K | |
| 2 | -$31K | |
| 3 | -$17.2K | |
| 4 |
Jane Street
New York
|
-$16.7K |
| 5 |
HF
HRT Financial
New York
|
-$6K |